Chimerix, Inc. (CMRX)
NASDAQ: CMRX · Real-Time Price · USD
8.55
0.00 (0.00%)
At close: Apr 17, 2025, 4:00 PM
8.54
-0.01 (-0.12%)
After-hours: Apr 17, 2025, 6:10 PM EDT
Chimerix Market Cap
Chimerix has a market cap or net worth of $801.08 million as of April 17, 2025. Its market cap has increased by 763.24% in one year.
Market Cap
801.08M
Enterprise Value
670.62M
1-Year Change
763.24%
Ranking
Category
Stock Price
$8.55
Market Cap Chart
Since April 11, 2013, Chimerix's market cap has increased from $435.70M to $801.08M, an increase of 83.86%. That is a compound annual growth rate of 5.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2025 | 801.10M | 155.94% |
| Dec 31, 2024 | 313.00M | 265.65% |
| Dec 29, 2023 | 85.60M | -47.74% |
| Dec 30, 2022 | 163.80M | -70.67% |
| Dec 31, 2021 | 558.50M | 84.63% |
| Dec 31, 2020 | 302.50M | 142.78% |
| Dec 31, 2019 | 124.60M | -4.45% |
| Dec 31, 2018 | 130.40M | -40.24% |
| Dec 29, 2017 | 218.20M | 2.39% |
| Dec 30, 2016 | 213.10M | -48.40% |
| Dec 31, 2015 | 413.00M | -71.88% |
| Dec 31, 2014 | 1.47B | 267.86% |
| Dec 31, 2013 | 399.20M | -8.38% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 766.34B |
| UnitedHealth Group | 409.94B |
| Johnson & Johnson | 383.38B |
| AbbVie | 309.57B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 229.75B |
| AstraZeneca | 210.38B |
| Novartis AG | 209.93B |